The Mitsunobu Inversion Reaction
1133
was as follows: at the end of the reaction, the reaction mixture was poured into water and allowed to
stand overnight. A dense oil formed, which was then separated from H2O and dissolved in CHCl3.
After drying and evaporation of the solvent, the residue was chromatographed on a silica gel column
with CHCl3.
Mitsunobu Esterification of 1 with Benzoic Acid
In toluene: A mixture of 286 mg of 1 (1mmol) and 305 mg of benzoic acid (2.5mmol) was treated in
15cm3 of toluene as described in the general procedure. The resulting crude product was chromato-
graphed on a silica gel column with CHCl3. The separation resulted in 83mg of 3 (31%), mp 108–
20
110ꢁC (Ref. [15] 107–109ꢁC), Rf ¼ 0.85 (ss A); ½ꢁꢃD ¼ ꢂ54 10ꢂ1 ꢁcm2 gꢂ1 (c ¼ 1, CHCl3); 1H NMR
(400 MHz, CDCl3, Me4Si): ꢂ ¼ 1.01 (d, J ¼ 7.0 Hz, 17-CH3), 1.30–2.65 (overlapping multiplets, 13H),
2.90 (m, 6-H2), 3.78 (s, 3-OCH3), 6.66 (d, J ¼ 2.6 Hz, 4-H), 6.72 (dd, J ¼ 8.6, 2.6Hz, 2-H), 7.26 (d,
J ¼ 8.6 Hz, 1-H) ppm; 13C NMR (100 MHz, CDCl3, Me4Si): ꢂ ¼ 19.5 (17-CH3), 24.1, 26.9, 27.2, 30.1,
31.3, 32.1, 39.8 (C-8), 41.3 (C-9), 41.7 (C-17), 55.2 (3-OCH3), 111.2 (C-2), 113.9 (C-4), 125.9 (C-1),
133.0 (C-10), 136.9 (C-13), 138.3 (C-14), 138.9 (C-5), 157.5 (C-3) ppm. Continued elution resulted
20
in 148 mg of 2a (38%), mp 98–101ꢁC, Rf ¼ 0.60 (ss A); ½ꢁꢃD ¼ ꢂ1710ꢂ1 ꢁcm2 gꢂ1 (c ¼ 1, CHCl3);
1H NMR (400MHz, CDCl3, Me4Si): ꢂ ¼ 0.86 (s, 18-H3), 1.30–2.40 (overlapping multiplets, 13H),
2.87 (m, 6-H2), 3.77 (s, 3-OCH3), 5.11 (d, J ¼ 6.0Hz, 17-H), 6.64 (d, J ¼ 2.6 Hz, 4-H), 6.71 (dd,
J ¼ 8.6, 2.6Hz, 2-H), 7.20 (d, J ¼ 8.6 Hz, 1-H), 7.45 (m, 30- and 50-H), 7.55 (t, J ¼ 7.3 Hz, 40-H), 8.06
(d, J ¼ 7.9 Hz, 20- and 60-H) ppm; 13C NMR (400MHz, CDCl3, Me4Si): ꢂ ¼ 16.8 (C-18), 24.5, 26.2,
28.1, 29.9, 30.3, 32.2, 39.1 (C-8), 43.7 (C-9), 45.4 (C-13), 49.5 (C-14), 55.2 (3-OCH3), 82.6 (C-17),
111.5 (C-2), 113.8 (C-4), 126.4 (C-1), 128.3 (2C, C-30 and C-50), 129.5 (2C, C-20 and C-60), 130.9
(C-10), 132.6 (C-10), 132.7 (C-40), 137.9 (C-5), 157.5 (C-3), 166.1 (C¼O) ppm. Further elution yielded
72mg of unreacted 1 (25%).
In chlorobenzene: A mixture of 286 mg of 1 (1mmol) and 305 mg of benzoic acid (2.5mmol) was
treated in 15cm3 of chlorobenzene as described in the general procedure. The resulting crude product
was chromatographed on a silica gel column with CHCl3. The separation resulted in 94 mg of 3 (35%),
117 mg of 2a (30%), and 92 mg of 1 (32%).
In HMPT: A mixture of 286 mg of 1 (1mmol) and 305 mg of benzoic acid (2.5mmol) was treated
in 15 cm3 of HMPT as described in the general procedure. The resulting crude product was chromato-
graphed on a silica gel column with CHCl3. The separation resulted in 32 mg of 3 (12%), 141 mg of 2a
(36%), and 137 mg of 1 (48%).
Mitsunobu Esterification of 1 with 4-Nitrobenzoic Acid
In toluene: A mixture of 286 mg of 1 (1mmol) and 418 mg of 4-nitrobenzoic acid (2.5mmol) was
treated in 15cm3 of toluene as described in the general procedure. The resulting crude product was
chromatographed on a silica gel column with CHCl3. The separation resulted in 16 mg of 3 (6%).
20
Continued elution resulted in 357 mg of 2b (82%), mp 154–155ꢁC, Rf ¼ 0.55 (ss A); ½ꢁꢃD
¼
1
ꢂ31 10ꢂ1 ꢁcm2 gꢂ1 (c ¼ 1, CHCl3); H NMR (400 MHz, CDCl3, Me4Si): ꢂ ¼ 0.88 (s, 18-H3), 1.35–
1.85 (overlapping multiplets, 8H), 1.95 (m, 2H), 2.38 (m, 3H), 2.88 (m, 6-H2), 3.78 (s, 3-OCH3), 5.15
(d, J ¼ 6.1 Hz, 17-H), 6.64 (d, J ¼ 2.7 Hz, 4-H), 6.71 (dd, J ¼ 8.6, 2.7 Hz, 2-H), 7.20 (d, J ¼ 8.6 Hz,
1-H), 8.22 (d, J ¼ 8.8 Hz, 20- and 60-H), 8.30 (d, J ¼ 8.8 Hz, 30- and 50-H) ppm; 13C NMR (100MHz,
CDCl3, Me4Si): ꢂ ¼ 16.8 (C-18), 24.4, 26.1, 28.1, 29.9, 30.2, 32.2, 39.1 (C-8), 43.7 (C-9), 45.5 (C-13),
49.6 (C-14), 55.2 (3-OCH3), 83.9 (C-17), 111.5 (C-2), 113.8 (C-4), 123.5 (2C, C-30 and C-50), 126.3
(C-1), 130.6 (2C, C-20 and C-60), 132.3 (C-10), 136.2 (C-10), 137.9 (C-5), 150.5 (C-40), 157.5 (C-3),
164.2 (C¼O) ppm. Further elution yielded 28mg of unreacted 1 (10%).
In chlorobenzene: A mixture of 286 mg of 1 (1 mmol) and 418 mg of 4-nitrobenzoic acid
(2.5mmol) was treated in 15 cm3 of chlorobenzene as described in the general procedure. The resulting